£4.2M
The Edinburgh biotech uses the capital to scale its 3D bioprinted tumour models across the UK, Europe, and the US.
C
Carcinotech
Carcinotech uses 3D bioprinting technology to simulate tumour microenvironments for cancer research.
Edinburgh, UK—Founded 2018
£4.2MTotal raised
Edinburgh-based biotech company developing 3D bioprinted tumour models to support cancer drug testing and personalised medicine.
Categories
Founders
IM
Ishani Malhotra
CEO and Founder